Inflammatory oedema associated with lopinavir-including HAART regimens in advanced HIV-1 infection: report of 3 cases.
Eyer-Silva
Walter A
WA
Neves-Motta
Rogério
R
Pinto
Jorge Francisco C
JF
Morais-De-Sá
Carlos Alberto
CA
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D004487:Edema / Q000139:chemically induced*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D015497:HIV-1; D006801:Humans; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000009:adverse effects* / Q000627:therapeutic use
D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir